-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Breakdown: Heron Therapeutics Q4

Benzinga·02/26/2026 13:02:13
Listen to the news

Heron Therapeutics (NASDAQ:HRTX) announced its Q4 earnings on Thursday, February 26, 2026 at 07:45 AM.

Here's a breakdown of the earnings report.

Earnings

Heron Therapeutics beat estimated earnings by 33.33%, reporting an EPS of $-0.02 versus an estimate of $-0.03.

Revenue was down $193 thousand from the same period last year.

Performance in Previous Earnings

The company missed on EPS by $0.02 in the last quarter, resulting in a 2.63% drop share price change the following day.

Here's a look at Heron Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.02 -0.01 -0.01 -0.03
EPS Actual -0.04 -0.02 0.01 0.02
Revenue Estimate 38.85M 38.01M 37.42M 37.37M
Revenue Actual 38.21M 37.20M 38.90M 40.78M

To track all earnings releases for Heron Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.